16th Annual School of Breast Oncology

16th Annual School of Breast Oncology is organized by Physicians Education Resource, LLC (PER) and will be held from Nov 01 - 03, 2018 at Emory Conference Center Hotel, Atlanta, Georgia, United States of America.

The target audience for this medical event is directed toward medical, radiation, and surgical oncologists whose primary practice focus is breast cancer and who intend to reinforce their knowledge base and expand their expertise in breast cancer diagnosis, treatment, and management. Participants will be primarily oncologists or fellows in training whose practice requires mastery and a critical understanding of the fundamental principles, pivotal published studies, and emerging information on the pathogenesis and management of breast cancer. This CME Conference has been approved for a maximum of 27 AMA PRA Category 1 Credits.

Conference Overview :
An increasing number of oncologists are focusing their clinical practices on the treatment of breast cancer, creating a need for specialized education. The School of Breast Oncology®, which has been held annually since 2003, was developed to advance patient care by providing a curriculum-based program focused exclusively on breast cancer clinical management. This intensive 3-day interactive program will provide a comprehensive review of data on the most important aspects of breast cancer biology, diagnostics, prevention, and treatment, with lectures emphasizing clinical implications presented by leading clinical investigators.

Conference Objectives :
At the conclusion of this activity, you should be better prepared to:
• Review breast cancer pathology, tumor biology, and prognostic/predictive markers in order to stratify risk among patients with breast cancer
• Discuss currently accepted diagnostic standards and imaging modalities for breast cancer
• Integrate biomarkers, molecular assays, and other risk assessment tools into clinical practice to optimize clinical decision-making for patients with breast cancer
• Describe current treatment standards concerning the use of surgical, radiation, and medical therapies for patients with breast cancer
• Describe strategies for the management of early-stage or locally advanced breast cancer
• Review methods to individualize the application of systemic therapies for patients with advanced breast cancer
• Discuss strategies to proactively mitigate proactively predictable treatment-related toxicities to optimize outcomes for patients with breast cancer
• Determine recent practice changing results from clinical trials and facilitate discussions with patients concerning eligibility for clinical trial opportunities

Additional details will be posted as soon as they are available.